These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Immunopathophysiologic mechanisms of cystic fibrosis lung disease. Soferman R Isr Med Assoc J; 2006 Jan; 8(1):44-8. PubMed ID: 16450752 [TBL] [Abstract][Full Text] [Related]
27. Cystic fibrosis enters the proteomics scene: new answers to old questions. Ollero M; Brouillard F; Edelman A Proteomics; 2006 Jul; 6(14):4084-99. PubMed ID: 16791827 [TBL] [Abstract][Full Text] [Related]
28. Pathophysiologic consequences following inhibition of a CFTR-dependent developmental cascade in the lung. Cohen JC; Larson JE BMC Dev Biol; 2005 Feb; 5():2. PubMed ID: 15694001 [TBL] [Abstract][Full Text] [Related]
29. Genetic and immunologic aspects of cystic fibrosis. Hilman BC Ann Allergy Asthma Immunol; 1997 Nov; 79(5):379-90; quiz 391-4. PubMed ID: 9396969 [TBL] [Abstract][Full Text] [Related]
30. Bicarbonate secretion in the murine gallbladder--lessons for the treatment of cystic fibrosis. Cuthbert AW JOP; 2001 Jul; 2(4 Suppl):257-62. PubMed ID: 11875268 [TBL] [Abstract][Full Text] [Related]
31. Challenges and strategies for cystic fibrosis lung gene therapy. Koehler DR; Hitt MM; Hu J Mol Ther; 2001 Aug; 4(2):84-91. PubMed ID: 11482978 [TBL] [Abstract][Full Text] [Related]
32. New pulmonary therapies for cystic fibrosis. Ratjen F Curr Opin Pulm Med; 2007 Nov; 13(6):541-6. PubMed ID: 17901762 [TBL] [Abstract][Full Text] [Related]
33. Genotype-phenotype correlation for pulmonary function in cystic fibrosis. de Gracia J; Mata F; Alvarez A; Casals T; Gatner S; Vendrell M; de la Rosa D; Guarner L; Hermosilla E Thorax; 2005 Jul; 60(7):558-63. PubMed ID: 15994263 [TBL] [Abstract][Full Text] [Related]
34. New therapies for cystic fibrosis. Simakajornboon N; Davis SH J La State Med Soc; 1998 Dec; 150(12):629-37. PubMed ID: 9926704 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic strategies for treatment of CF based on knowledge of CFTR. Riordan JR Pediatr Pulmonol Suppl; 1999; 18():83-7. PubMed ID: 10093106 [TBL] [Abstract][Full Text] [Related]
36. Association of common haplotypes of surfactant protein A1 and A2 (SFTPA1 and SFTPA2) genes with severity of lung disease in cystic fibrosis. Choi EH; Ehrmantraut M; Foster CB; Moss J; Chanock SJ Pediatr Pulmonol; 2006 Mar; 41(3):255-62. PubMed ID: 16429424 [TBL] [Abstract][Full Text] [Related]
37. Perioperative management of the adult with cystic fibrosis. Huffmyer JL; Littlewood KE; Nemergut EC Anesth Analg; 2009 Dec; 109(6):1949-61. PubMed ID: 19923526 [TBL] [Abstract][Full Text] [Related]
38. Mouse models of cystic fibrosis: phenotypic analysis and research applications. Wilke M; Buijs-Offerman RM; Aarbiou J; Colledge WH; Sheppard DN; Touqui L; Bot A; Jorna H; de Jonge HR; Scholte BJ J Cyst Fibros; 2011 Jun; 10 Suppl 2():S152-71. PubMed ID: 21658634 [TBL] [Abstract][Full Text] [Related]
39. Cystic fibrosis-associated liver disease. Herrmann U; Dockter G; Lammert F Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):585-92. PubMed ID: 20955961 [TBL] [Abstract][Full Text] [Related]
40. Cystic fibrosis in adults. From researcher to practitioner. Marelich GP; Cross CE West J Med; 1996 Apr; 164(4):321-34. PubMed ID: 8732732 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]